A carregar...
Mineralocorticoid Receptor Antagonists for Treatment of Hypertension and Heart Failure
Spironolactone and eplerenone are both mineralocorticoid-receptor antagonists. These compounds block both the epithelial and nonepithelial actions of aldosterone, with the latter assuming increasing clinical relevance. Spironolactone and eplerenone both affect reductions in blood pressure either as...
Na minha lista:
| Publicado no: | Methodist Debakey Cardiovasc J |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Methodist Hospital Houston, Texas
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4814010/ https://ncbi.nlm.nih.gov/pubmed/27057293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-11-4-235 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|